Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

RSS icon
transgender gender LGBT LGBTQ

Hormone therapy for gender dysphoria linked to higher cardiovascular risks

“It's all about risks and benefits," one researcher said. "Starting transitioning is a big part of a person's life and helping them feel more themselves, but hormone replacement therapy also has a lot of side effects—it's not a risk-free endeavor."

Confirmed: Long COVID more than doubles a person’s risk of heart issues

According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. 

Yes, COVID-19 increases a person’s diabetes risk—but vaccination may help

Patients who are vaccinated at the time of their COVID-19 diagnosis appear to face a lower risk of new-onset type 2 diabetes than patients who are not vaccinated. 

FDA calls out weight loss pills for ‘hidden’ ingredient that puts health of heart patients at risk Alfia Weight Loss Capsules

FDA calls out weight loss pills for ‘hidden’ ingredient that puts health of heart patients at risk

The agency’s own analysis confirmed that these capsules contain sibutramine, which was removed from the market back in 2010 due to safety concerns

Image courtesy of the University of Missouri Zheng Yan, PhD

Researchers design new material for wearable devices: ‘You cannot feel it, and you will likely forget about it’

The soft, stretchable material creates so little pressure that users will likely not even even be able to feel it. 

IVF, other fertility treatments do not put the heart health of children at risk

Parents who are currently considering the use of fertility treatments such as IVF may want to read this study closely. 

FDA approves new medication for type 2 diabetes

The newly approved SGLT2 inhibitor, bexagliflozin, is marketed under the name Brenzavvy. It is not recommended for patients with type 1 diabetes. 

Cardiologist Martha Gulati, MD, who specializes in both preventive cardiology and cardiovascular disease in women, has been named the Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research at Cedars-Sinai in Los Angeles.

Cardiologist Martha Gulati named chair of women’s cardiovascular medicine and research at Cedars-Sinai

Gulati, an award-winning cardiologist and author, first joined Cedars-Sinai in 2022. She is also the president of the American Society for Preventive Cardiology.

Displaying 241 - 248 of 990
Design by Adaptive Theme